Foley & Lardner LLP represented Mevo, a Brazilian health care startup, in its $19 million Series B funding round. The round was led by Matrix, with participation from Jefferson River Capital.
Founded in 2017, Mevo was created to become the infrastructure for e-prescriptions in Brazil, addressing a critical need where over 150 million Brazilians are still holding a handwritten medical prescription. Mevo’s technology enables health care providers in Brazil to issue digital prescriptions which patients can then use to purchase prescriptions at any pharmacy of their choice, including at Mevo’s own pharmacy marketplace. Today, over 10 million patients have received at least one Mevo prescription and all Brazilian pharmacies (more than 80,000) accept and can process a Mevo prescription.
Mevo plans to use the funding to expand its network of health care provider partners, enhance its digital prescription and pharmacy marketplace platform, and explore additional health care services beyond the fulfillment of prescriptions.
The Foley team was led by partner André Thiollier and included tax partner James Howard and associates Talita Duarte and Trevor Mullin.